Skip to main content

Animations

MJFF Publications

6811 - 6820 of 8808 Results
Title
Year
  • Year
  • 2017
  • 2020
  • 2024
  • 2022
  • 2015
  • 2022
  • 2017
  • 2019
  • 2022
  • 2019
  • Summary Details
    OPEN
    Title: Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's disease
    Journal Name: The Journal of Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/path.4929
    Citation Count: 127
  • Summary Details
    RESTRICTED
    Title: From correlational approaches to meta-analytical symptom reading in individual patients: Bilateral lesions in the inferior frontal junction specifically cause dysexecutive syndrome
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cortex.2020.03.010
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29925
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s disease
    Journal Name: Environment International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.envint.2022.107613
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b00571
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13414
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Ubiquitin Linkage-Specific Affimers Reveal Insights into K6-Linked Ubiquitin Signaling
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2017.08.020
    Citation Count: 179
  • Summary Details
    OPEN
    Title: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9
    Citation Count: 123
  • Summary Details
    OPEN
    Title: Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients
    Journal Name: Metabolites
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/metabo12020149
    Citation Count: 14
  • Summary Details
    OPEN
    Title: ToolBox: Live Imaging of intracellular organelle transport in induced pluripotent stem cell‐derived neurons
    Journal Name: Traffic
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/tra.12701
    Citation Count: 52
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.